Gabriel Lopez-Berestein

Bellaire, TX, United States of America

Gabriel Lopez-Berestein

USPTO Granted Patents = 42 

Average Co-Inventor Count = 3.4

ph-index = 16

Forward Citations = 909(Granted Patents)


Location History:

  • Harris, TX (US) (1991 - 1993)
  • Bellaire, TX (US) (1999 - 2020)
  • Houston, TX (US) (1987 - 2024)

Company Filing History:


Years Active: 1987-2024

Loading Chart...
42 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gabriel Lopez-Berestein in Cancer Treatment

Introduction

Gabriel Lopez-Berestein, a prominent inventor based in Bellaire, TX, has made significant strides in the field of cancer treatment through his innovative research and development of therapeutic solutions. With an impressive portfolio of 42 patents, his work is paving the way for new methodologies in medicine, particularly concerning cancer therapies.

Latest Patents

Among his latest inventions, Lopez-Berestein has developed DNA aptamers specifically targeting the AXL receptor kinase. These aptamers feature a thiophosphate backbone that can be chemically modified, providing methods for treating diseases such as cancer. Additionally, he has introduced dual assembly nanoparticles designed for the delivery of therapeutic or diagnostic agents. These nanoparticles consist of chitosan and polyphosphate, with chitosan nanoparticles coated in polylactic acid. This innovative approach is particularly effective for treating ovarian cancer by inhibiting the expression of ZNF034.

Career Highlights

Throughout his career, Lopez-Berestein has worked with esteemed institutions, including the University of Texas System and Aronex Pharmaceuticals, Inc. His tenure at these organizations has enabled him to collaborate on various groundbreaking projects, furthering the potential in cancer research and treatment methodologies.

Collaborations

Lopez-Berestein has had the opportunity to work alongside talented colleagues like Ana Maria Tari and Reeta Mehta. Their combined expertise has enhanced the impact of Lopez-Berestein’s research, fostering an environment ripe for innovation and advancement in medical therapies.

Conclusion

In summary, Gabriel Lopez-Berestein's contributions to cancer treatment through his patent portfolio and collaborative efforts position him as a leading figure in the field. His innovative approach not only addresses critical medical challenges but also provides hope for improved therapeutic outcomes for patients suffering from cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…